Prevention of cardio-renal syndromes: Workgroup statements from the 7th ADQI Consensus Conference

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1777-1784

  McCullough, Peter A ^a   Haapio, Mikko ^b   Mankad, Sunil ^c   Zamperetti, Nereo ^d   Massie, Barry ^e   Bellomo, Rinaldo ^f   Berl, Tomas ^g   Anker, Stefan D ^h,i   Anand, Inder ^j   Aspromonte, Nadia ^k   Bagshaw, Sean M ^l   Bobek, Ilona ^d   Cruz, Dinna N ^d,m   Daliento, Luciano ⁿ   Davenport, Andrew ^o   Hillege, Hans ^p   House, Andrew A ^q   Katz, Nevin ^r   Maisel, Alan ^j   Mebazaa, Alexandre ^s   Palazzuoli, Alberto ^t   Ponikowski, Piotr ^u   Ronco, Federico ⁿ   Shaw, Andrew ^v   Sheinfeld, Geoff ^w   Soni, Sachin ^d,x   Vescovo, Giorgio ^d   Zanco, Pierluigi ^d   Ronco, Claudio ^d   more..

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c MAYO CLINIC   (United States)

^d SAN BORTOLO HOSPITAL   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f AUSTIN HOSPITAL   (Australia)

^g UNIVERSITY OF COLORADO   (United States)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ IRCCS SAN RAFFAELE PISANA   (Italy)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

^k SPIRITO SANTO HOSPITAL   (Italy)

^l UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^m International Renal Research Institute Vicenza (IRRIV)   (Italy)

ⁿ UNIVERSITY OF PADOVA   (Italy)

^o ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^p UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^q LONDON HEALTH SCIENCES CENTRE   (Canada)

^r GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^s HÔPITAL LARIBOISIÈRE   (France)

^t UNIVERSITY OF SIENA   (Italy)

^u WROCLAW MEDICAL UNIVERSITY   (Poland)

^v DUKE UNIVERSITY MEDICAL CENTER   (United States)

^w UNIVERSITY OF MARYLAND   (United States)

^x Division of Nephrology   (India)

more..

Author keywords

Acute kidney injury; Cardio renal syndromes; Chronic kidney disease; Decompensated heart failure; Heart failure; Mortality; Outcomes; Prevention; Reno cardiac syndrome

Indexed keywords

ACUTE CORONARY SYNDROME; ALBUMINURIA; CARDIO RENAL SYNDROME; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; GLOMERULUS FILTRATION RATE; HEART FAILURE; PRIORITY JOURNAL;

ACUTE DISEASE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HEART FAILURE; HUMANS; KIDNEY DISEASES; RENAL INSUFFICIENCY, ACUTE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SYNDROME;

EID: 77952969744     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq180     Document Type: Conference Paper

References (64)

1. Whaley-Connell AT, Sowers JR et al. Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S21-S29
2. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
3. Brosius FC 3rd, Hostetter TH, Kelepouris E et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in Collaboration With the National Kidney Foundation. Hypertension 2006; 48: 751-755
4. McCullough PA, Li S, Jurkovitz CT et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2008; 51: S38-S45 (Pubitemid 351444716)
5. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (R.EA.C.H.) Study. J Am Coll Cardiol 2002; 39: 60-69
6. Ronco C, McCullough PA, Anker SD et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J2009; 31: 703-711
7. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 2002; 3: 71-76
8. Patel UD, Hernandez AF, Liang L et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines\Heart Failure Program study. Am Heart J2008; 156: 674-681
9. Ronco C, House AA, Haapio M. Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34: 957-962
10. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539
11. Endre ZH. Acute kidney injury: definitions and new paradigms. Adv Chronic Kidney Dis 2008; 15: 213-221
12. Opasich C, Rapezzi C, Lucci D et al. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol 2001; 88: 382-387
13. Fonarow GC, Abraham WT, Albert NM et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF Arch Intern Med 2008; 168: 847-854
14. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure traits among urban blacks. Arch Intern Med 1988; 148: 2013-2016
15. Giordano A, Scalvini S, Zanelli E et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol 2008; 131: 192-199
16. López Cabezas C, Falces Salvador C, Cubí Quadrada D et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. Farm Hosp 2006; 30: 328-342
17. Murray MD, Young J, Hoke S et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007; 146: 714-725
18. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819
19. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemo-nitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007; 334: 942
20. Gowda RM, Fox JT, Khan IA. Cardiogenic shock: basics and clinical considerations. Int J Cardiol 2008; 123: 221-228
21. Becker RC, Meade TW, Berger PB et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 776S-814S
22. Fonarow GC. Acute decompensated heart failure: challenges and opportunities. Rev Cardiovasc Med 2007; 8: S3-S12
23. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. J Am Coll Cardiol 2005; 46: e1-e82
24. Boerrigter G, Costello-Boerrigter LC, Abraham WT et al. Cardiac resynchronization therapy with biventricular pacing improves renal function in heart failure patients with reduced glomerular filtration rate. Circulation 2007; 116: II-405
25. Hasselblad V, Gattis Stough W, Shah MR et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007; 9: 1064-1069
26. Metra M, Nodari S, Parrinello G et al. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 2008; 10: 188-195
27. Ahmed A, Husain A, Love TE et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006; 27: 1431-1439
28. J-MELODIC Program Committee. Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long-vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circ J 2007; 71: 1137-1140
29. Goebel JA, Van Bakel AB. Rational use of diuretics in acute decom-pensated heart failure. Curr Heart Fail Rep 2008; 5: 153-162
30. Silvers SM, Howell JM, Kosowsky JM, Rokos IC, Jagoda AS. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Ann Emerg Med 2007; 49: 627-669
31. McCullough PA, Lepor NE. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment. Rev Cardiovasc Med 2005; 6: 1-10
32. Jones M, Schenkel B, Just J. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality. Int J Cardiol 2005; 100: 253-265
33. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501-511
34. Mukherjee D. Nonsteroidal anti-inflammatory drugs and the heart: what is the danger?. Congest Heart Fail 2008; 14: 75-82
35. McCullough PA, Adam A, Becker CR et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006; 98: 27-36
36. DiBona GF. Prostaglandins and nonsteroidal anti-inflammatory drugs. Effects on renal hemodynamics. Am J Med 1986; 80: 12-21
37. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558
38. McCullough PA. Acute kidney injury with iodinated contrast. Crit Care Med 2008; 36: S204-S211
39. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375
40. Marenzi G, Bartorelli AL. Recent advances in the prevention of radiocontrast-induced nephropathy. Curr Opin Crit Care 2004; 10: 505-509
41. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340
42. Marenzi G, Lauri G, Campodonico J et al. Comparison of two he-mofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006; 119: 155-162
43. Schetz M, Bove T, Morelli A, Mankad S, Ronco C, Kellum JA. Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs 2008; 31: 179-189 (Pubitemid 351436159)
44. Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis 2008; 15: 222-234
45. McCullough PA. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens 2004; 13: 591-600
46. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169
47. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
48. David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant 2008; 23: 1370-1377
49. de Zeeuw D, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in Type 2 diabetic patients with ne-phropathy. Circulation 2004; 110: 921-927
50. deFilippi CR, Thorn EM, Aggarwal M et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007; 100: 885-889
51. Wang AY, Lam CW, Wang M et al. Prognostic value of cardiac tro-ponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem 2007; 53: 882-889
52. McCullough PA. Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. Kidney Int Suppl 2005 s51-s58
53. Bonello L, De Labriolle A, Roy P et al. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008; 102: 535-540
54. Dumler F, McCullough PA. Optimal dialysis for the end-stage renal disease patient with cardiovascular disease. Adv Chronic Kidney Dis 2004; 11: 261-273
55. Selby NM, Burton JO, Chesterton LJ, McIntyre CW. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1: 1216-1225
56. Faraz HA, Zafar SF, Ghali JK. Anemia and the potential role of erythropoiesis-stimulating agents in heart failure. Curr Heart Fail Rep 2008; 5: 83-90
57. Fellström B, Holdaas H, Jardine AG et al. Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney Blood Press Res 2007; 30: 314-322
58. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with Type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248 (Pubitemid 41058323)
59. Fellström BC, Jardine AG, Schmieder RE et al. Rosuvastatin, cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407 Epub 2009 Mar 30
60. Jamison RL, Hartigan P, Kaufman JS et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007; 298: 1163-1170
61. Pfeffer MA, Burdmann EA, Chen CY et al. A trial of darbepoetin alfa in Type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-2032
62. Agrawal V, Barnes MA, Ghosh AK, McCullough PA. Questionnaire instrument to assess knowledge of chronic kidney disease clinical practice guidelines among internal medicine residents. J Eval Clin Pract 2009; 15: 733-738
63. Agrawal V, Agarwal M, Ghosh AK, Barnes MA, McCullough PA. Identification and management of chronic kidney disease complications by internal medicine residents a national survey. Am J Ther 2009 Epub ahead of print
64. McCullough PA, Whaley-Connell A, Brown WWet al. Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program. Intern Med J 2010 Epub ahead of print